YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
12.89
+0.41 (3.29%)
Dec 26, 2025, 11:34 AM EST - Market open
YD Bio Market Cap
YD Bio has a market cap or net worth of $906.42 million as of December 26, 2025. Its market cap has increased by 1,757.55% in one year.
Market Cap
906.42M
Enterprise Value
874.48M
1-Year Change
1,757.55%
Ranking
Category
Stock Price
$12.89
Market Cap Chart
Since December 23, 2020, YD Bio's market cap has increased from $148.36M to $906.42M, an increase of 510.98%. That is a compound annual growth rate of 43.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 877.59M | 1,833.90% |
| Dec 26, 2024 | 45.38M | -4.31% |
| Dec 28, 2023 | 47.42M | -5.87% |
| Dec 30, 2022 | 50.38M | -66.30% |
| Dec 31, 2021 | 149.47M | 3.24% |
| Dec 31, 2020 | 144.79M | -2.40% |
| Dec 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.31B |
| Johnson & Johnson | 500.60B |
| AbbVie | 406.30B |
| UnitedHealth Group | 296.73B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 232.28B |